HHealthcare Read More 2 Top AI Healthcare Stocks to Buy and HoldMarch 10, 2026 Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
HHealthcare Read More Eli Lilly on track to launch oral obesity drug in second quarter, pending US approvalMarch 5, 2026 March 2 (Reuters) – Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its…
HHealthcare Read More The Best Healthcare Stock to Invest $1,000 in Right NowMarch 3, 2026 When you think “top-performing pharma stock,” Eli Lilly may first come to mind. Yet while Lilly’s shares have…
MMedication Read More 1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market CrashFebruary 26, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
EEconomy Read More Why haven’t Trump’s tariffs caused a downturn in the US? – The Irish TimesFebruary 22, 2026 When Donald Trump famously announced his Liberation Day tariff assault on the world last April, economists, almost en…
MMedication Read More NHS must keep medicine rebate down or lose investmentFebruary 19, 2026 Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
HHealthcare Read More JPMorgan builds $2.93 billion stake in health care stockFebruary 17, 2026 JPMorgan Chase just planted a massive $2.93 billion flag in perhaps one of the hottest corners of the…
AArtificial intelligence Read More This Pharma Giant Is Using AI to Dominate Drug DiscoveryFebruary 16, 2026 There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
HHealthcare Read More New peptide drugs on the horizon with PepLib–Lilly collabFebruary 11, 2026 New global partnership aims to turn PepLib’s peptide tech into therapies that could reshape treatment and longevity. Think…
HHealthcare Read More What’s the Better Long-Term Investment?February 10, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 5, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
HHealthcare Read More Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026February 4, 2026 Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…